Debra Murwin

Debra Murwin currently serves as the Director of Clinical Development at Avalyn Pharma, a position held since March 2025. Prior to this role, Debra was with Boehringer Ingelheim from June 2013 to March 2025, where responsibilities included leading cross-functional teams as a Director-Integration Lead and overseeing clinical operations in the US Cardiovascular Pipeline as a Team Leader. Debra also served as the Strategic Alliance Lead in Clinical Operations, facilitating strategy development and operational execution across various therapeutic areas. Debra holds a BS in Biology from The Ohio State University, completed in 1991, and an MBA from The Ohio State University Fisher College of Business, earned in 2008.